Amylyx Pharmaceuticals, Inc. · NASDAQ:AMLX
Point72 Asset Management, L.P.'s stake in Amylyx Pharmaceuticals, Inc. fell to 2.60% (Schedule 13G/A)
Event Sep 30, 2025 · Filed Nov 14, 2025
Point72 Asset Management, L.P.'s stake in Amylyx Pharmaceuticals, Inc. fell to 2.60%, 2,801,636 shares, as a passive investor on Sep 30, 2025. Filed Nov 14, 2025 (Schedule 13G/A).
- Stake
- 2.60%
- Shares
- 2,801,636
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Point72 Asset Management, L.P. | 2.60% | 2,801,636 |
| Point72 Capital Advisors, Inc. | 2.60% | 2,801,636 |
| Steven A. Cohen | 2.60% | 2,801,636 |
Source
Related
- Amylyx Pharmaceuticals, Inc.
- Point72 Asset Management, L.P.
- Amylyx Pharmaceuticals, Inc. shareholders
- Schedule 13G · Point72 Asset Management, L.P. · Jun 25, 2025
- Schedule 13G/A · Point72 Asset Management, L.P. · May 15, 2025
- Schedule 13G · Point72 Asset Management, L.P. · Jan 14, 2025
- Form 4 · Milne George M Jr · Oct 7, 2026
- Form 4 · Bedrosian Camille L · Sep 14, 2026
- Form 4 · Frates James M · Sep 14, 2026
- Form 4 · Mazzariello Gina · Sep 14, 2026
- Form 4 · Cohen Joshua B · Sep 14, 2026